# Trial of Exenatide for Parkinson's Disease

> **NCT01971242** · PHASE2 · COMPLETED · sponsor: **University College, London** · enrollment: 60 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Exenatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01971242
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-05
- **Final completion:** 2016-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01971242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01971242, "Trial of Exenatide for Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01971242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*